Bio-Rad Laboratories | BIO - Operating Expenses

Stock Price
262.76
Daily Change
-0.04 -0.02%
Monthly
-0.82%
Yearly
2.50%
Q1 Forecast
254.86

Bio-Rad Laboratories reported $6.74B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Merck USD 10.16B 558M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 229M 3.4M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 16.57B 2.29B Dec/2025
Standard Biotools USD 43.02M 2.44M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Tosoh JPY 231.79B 6.44B Dec/2025
Waters USD 661.85M 1.67B Dec/2025